Annex, B.H., Williams, R.S., 1990.

Mitochondrial DNA structure and expression in

specialized subtypes of mammalian striated muscle. Mol. Cell. Biol. 10, 5671
5678. doi:10.1128/MCB.10.11.5671.Updated
Antonetti, D.A., Reynet, C., Kahn, C.R., 1995. Increased expression of
mitochondrial-encoded genes in skeletal muscle of humans with diabetes
mellitus. J. Clin. Invest. 95, 13831388. doi:10.1172/JCI117790
Apostolova, N., Ballesteros, D., Monleo, D., Morales, J.M., Blas-garc, A., Rocha,
M., Victor, V.M., Esplugues, J. V, 2010. Inhibition of Mitochondrial Function by
Efavirenz Increases Lipid Content in Hepatic Cells 115125.
doi:10.1002/hep.23647
Apostolova, N., Gomez-Sucerquia, L.J., Gortat, A., Blas-Garcia, A., Esplugues, J. V,
2011. Autophagy as a rescue mechanism in Efavirenz-induced mitochondrial
dysfunction: A lesson from hepatic cells. Autophagy 7, 14021404.
doi:10.4161/auto.7.11.17653
Apostolova, N., Gomez-sucerquia, L.J., Moran, A., Alvarez, A., 2010. Enhanced
oxidative stress and increased mitochondrial mass during Efavirenz-induced
apoptosis in human hepatic cells. Br. J. Pharmacol. doi:10.1111/j.14765381.2010.00866.x
Arnoult, D., 2007. Mitochondrial fragmentation in apoptosis. Trends Cell Biol. 17,
612. doi:10.1016/j.tcb.2006.11.001
Autophagy, S., Apostolova, N., Gomez-sucerquia, L.J., Gortat, A., Blas-garcia, A.,
Esplugues, J. V, 2011. Compromising Mitochondrial Function with the
Antiretroviral Drug Efavirenz Induces Cell Survival-Promoting Autophagy.
Hepatology. doi:10.1002/hep.24459
Caggiari, L., Zanussi, S., Bortolin, M.T., Dandrea, M., Nasti, G., Simonelli, C.,
Tirelli, U., De Paoli, P., 2000. Effects of therapy with highly active anti-retroviral
therapy (HAART) and IL-2 on CD4+ and CD8+ lymphocyte apoptosis in HIV+
patients., Clinical and experimental immunology. doi:cei1187 [pii]
Carr, A., Cooper, D.A., 2000. Adverse drug reactions Adverse effects of
antiretroviral therapy. Lancet 356, 14231430.
Chaitanya, G.V., Steven, A.J., Babu, P.P., 2010. PARP-1 cleavage fragments:
signatures of cell-death proteases in neurodegeneration. Cell Commun. Signal. 8,
31. doi:10.1186/1478-811X-8-31
Chan, D.C., 2006. Mitochondria: dynamic organelles in disease, aging, and
development. Cell 125, 124152. doi:10.1016/j.cell.2006.06.010
Chazotte, B., 2011. Labeling mitochondria with JC-1. Cold Spring Harb. Protoc.
2011, 11031104. doi:10.1101/pdb.prot065490
Clercq, E. De, 2002. New developments in anti-HIV chemotherapy $. Biochim.
Biophys. Acta 1587, 258275.

Ct, H.C.F., Brumme, Z.L., Craib, K.J.P., Alexander, C.S., Wynhoven, B., Ting, L.,
Wong, H., Harris, M., Harrigan, P.R., OShaughnessy, M. V, Montaner, J.S.G., 2002.
Changes in mitochondrial DNA as a marker of nucleoside toxicity in HIV-infected
patients. N. Engl. J. Med. 346, 81120. doi:10.1056/NEJMoa012035
Dario Leister, J.M.H., 2007. mitochondria practical protocols. Methods Mol. Biol.
372.
Detels, R., Mun, A., Mcfarlane, G., Kingsley, L.A., Margolick, J.B., Giorgi, J.,
Schrager, L.K., Phair, J.P., 1998. Effectiveness of Potent Antiretroviral Therapy on
Time to AIDS and Death in Men With Known HIV Infection Duration 280, 1497
1503.
Dieterich, D.T., Robinson, P.A., Love, J., Stern, J.O., 2004. Drug-Induced Liver
Injury Associated with the Use of Nonnucleoside Reverse-Transcriptase Inhibitors
10029.
Dummin, H., Cernay, T., Zimmermann, H.W., 1997. Selective photosensitization
of mitochondria in HeLa cells by cationic Zn(II)phthalocyanines with lipophilic
side-chains. J. Photochem. Photobiol. B Biol. 37, 219229. doi:10.1016/S10111344(96)07416-7
Fiala, M., Murphy, T., MacDougall, J., Yang, W., Luque, A., Iruela-Arispe, L.,
Cashman, J., Buga, G., Byrns, R.E., Barbaro, G., Arthos, J., 2004. HAART drugs
induce mitochondrial damage and intercellular gaps and gp120 causes
apoptosis. Cardiovasc. Toxicol. 4, 327337.
Figueiredo, A., Moore, K.L., Mak, J., Sluis-cremer, N., Bethune, M. De, Tachedjian,
G., 2006. Potent Nonnucleoside Reverse Transcriptase Inhibitors Target HIV-1
Gag-Pol. plos Pathog. 2. doi:10.1371/journal.ppat.0020119
Frederick M. Ausubel, Roger Brent, Robert E. Kingston, et al, 2003. Current
Protocols in Molecular Biology, wiley.
Frezza, C., Cipolat, S., Scorrano, L., 2007. Organelle isolation: functional
mitochondria from mouse liver, muscle and cultured fibroblasts. Nat. Protoc. 2,
287295.
Gallagher, S., Winston, S.E., Fuller, S.A., Hurrell, J.G.R., 2011. Immunoblotting and
immunodetection. Curr. Protoc. Cell Biol. doi:10.1002/0471143030.cb0602s52
Gallego-Escuredo, J.M., Del Mar Gutierrez, M., Diaz-Delfin, J., Domingo, J.C.,
Mateo, M.G., Domingo, P., Giralt, M., Villarroya, F., 2010. Differential effects of
efavirenz and lopinavir/ritonavir on human adipocyte differentiation, gene
expression and release of adipokines and pro-inflammatory cytokines. Curr. HIV
Res. 8, 54553.
Gomez-sucerquia, L.J., Blas-garcia, A., Marti-cabrera, M., Esplugues, J. V,
Apostolova, N., 2012. Profile of stress and toxicity gene expression in human
hepatic cells treated with Efavirenz. Antiviral Res. 94, 232241.
doi:10.1016/j.antiviral.2012.04.003

Gounden, V., Niekerk, C. Van, Snyman, T., George, J.A., 2010. Presence of the
CYP2B6 516G > T polymorphism , increased plasma Efavirenz concentrations
and early neuropsychiatric side effects in South African HIV-infected patients.
AIDS Res. Ther. 19.
Gutierrez, M.E., Canton, A., Sosa, N., Puga, E., Talavera, L., 2005. Disseminated
histoplasmosis in patients with AIDS in Panama: a review of 104 cases. Clin.
Infect. Dis. 40, 1199202. doi:10.1086/428842
Hamrapurkar, P.D., Patil, P.S., Phale, M.D., Shah, N., Pawar, S.B., 2010.
Optimization and Validation of Rp-Hplc Stability-Indicating Method for
Determination of Efavirenz and its Degradation Products. Int. J. Appl. Sci. 8, 155
165.
Heller, A., Brockhoff, G., Goepferich, A., 2012. Targeting drugs to mitochondria.
Eur. J. Pharm. Biopharm. doi:10.1016/j.ejpb.2012.05.014
Hori, R., Okumura, K., Yoshida, H., 1987. Binding of basic drugs to rat lung
mitochondria. Pharm. Res. 4, 142146.
Kakuda, T.N., 2000. Pharmacology of nucleoside and nucleotide reverse
transcriptase inhibitor-induced mitochondrial toxicity. Clin. Ther. 22, 685708.
Karamchand, L., Dawood, H., Chuturgoon, A. a, 2008. Lymphocyte mitochondrial
depolarization and apoptosis in HIV-1-infected HAART patients. J. Acquir. Immune
Defic. Syndr. 48, 3818. doi:10.1097/QAI.0b013e3181799662
King, J., Aberg, J.A., 2008. Clinical impact of patient population differences and
genomic variation in efavirenz therapy. AIDS 17091717.
doi:10.1097/QAD.0b013e32830163ad
Kwara, A., Lartey, M., Sagoe, K.W., Rzek, N.L., Court, M.H., 2009. CYP2B6 ( c .
516G T ) and polymorphisms are independent predictors of efavirenz plasma
concentrations in HIV-infected patients. Br. J. Clin. Pharmacol. 6.
doi:10.1111/j.1365-2125.2009.03368.x
Lewis, W., Day, B.J., Copeland, W.C., 2003a. MITOCHONDRIAL TOXICITY OF NRTI
ANTIVIRAL DRUGS: AN INTEGRATED CELLULAR PERSPECTIVE. Nat. Rev. Drug
Discov. 2, 812822. doi:10.1038/nrd1201
Lewis, W., Day, B.J., Copeland, W.C., 2003b. MITOCHONDRIAL TOXICITY OF NRTI
ANTIVIRAL DRUGS: AN INTEGRATED CELLULAR PERSPECTIVE 2, 812822.
doi:10.1038/nrd1201
Li, P., Nijhawan, D., Budihardjo, I., Srinivasula, S.M., Ahmad, M., Alnemri, E.S.,
Wang, X., 1997. Cytochrome c and dATP-dependent formation of Apaf-1/caspase9 complex initiates an apoptotic protease cascade. Cell 91, 479489.
doi:10.1016/S0092-8674(00)80434-1
Luo, M., Lu, Z., Sun, H., Yuan, K., Zhang, Q., Meng, S., Wang, F., Guo, H., Ju, X.,
Liu, Y., Ye, T., Lu, Z., Zhai, Z., 2010. Nuclear entry of active caspase-3 is facilitated

by its p3-recognition-based specific cleavage activity. Cell Res. 20, 211222.

doi:10.1038/cr.2010.9
Maggiolo, F., Diseases, I., Riuniti, O., Barozzi, L., 2009a. Efavirenz: a decade of
clinical experience in the treatment of HIV 910928. doi:10.1093/jac/dkp334
Maggiolo, F., Diseases, I., Riuniti, O., Barozzi, L., 2009b. Efavirenz: a decade of
clinical experience in the treatment of HIV. J. Antimicrob. Chemother. 910928.
doi:10.1093/jac/dkp334
Manfredi, R., Calza, L., Chiodo, F., 2004. Efavirenz versus nevirapine in current
clinical practice: a prospective, open-label observational study., Journal of
Acquired Immune Deficiency Syndromes.
Manoli, I., Alesci, S., Blackman, M.R., Su, Y. a, Rennert, O.M., Chrousos, G.P., 2007.
Mitochondria as key components of the stress response. Trends Endocrinol.
Metab. 18, 1908. doi:10.1016/j.tem.2007.04.004
Martin, J.L., Brown, C.E., Matthews-Davis, N., Reardon, J.E., 1994. Effects of
antiviral nucleoside analogs on human DNA polymerases and mitochondrial DNA
synthesis. Antimicrob. Agents Chemother. 38, 27432749.
Martin, N.C., Hopper, A.K., 1994. How single genes provide tRNA processing
enzymes to mitochondria, nuclei and the cytosol. Biochimie 76, 11611167.
Marzolini, C., Telenti, A., Decosterd, L.A., Greub, G., 2001. Efavirenz plasma levels
can predict treatment failure and central nervous system side effects in HIV-1infected patients. AIDS.
Matthews, C.Z., Woolf, E.J., Mazenko, R.S., Haddix-wiener, H., 2002.
Determination of efavirenz , a selective non-nucleoside reverse transcriptase
inhibitor , in human plasma using HPLC with post-column photochemical
derivatization and fluorescence detection. J. Pharm. Biomed. Anal. 28, 925934.
Mendoza, C. De, Snchez-conde, M., Timmermans, E., Buitelaar, M., De, M.P.,
2005. Mitochondrial DNA depletion in HIV-infected patients is more pronounced
with chronic hepatitis C and enhanced following treatment with pegylated
interferon plus ribavirin. Antivir. Ther. 557561.
Meynard, J., Lacombe, K., Poirier, J., Legrand, J., Morand-joubert, L., Girard, P.,
Infectieuses, M., Publique-ho, A., Pharmacie, S. De, 2009. Influence of liver
fibrosis stage on plasma levels of efavirenz in HIV-infected patients with chronic
hepatitis B or C. J. Antimicrob. Chemother. 579584. doi:10.1093/jac/dkn531
Mosmann, T., 1983. Rapid colorimetric assay for cellular growth and survival:
Application to proliferation and cytotoxicity assays. J. Immunol. Methods 65, 55
63. doi:http://dx.doi.org/10.1016/0022-1759(83)90303-4
Murphy, M.P., 2008. Targeting lipophilic cations to mitochondria. Biochim.
Biophys. Acta - Bioenerg. doi:10.1016/j.bbabio.2008.03.029

Novak, I., 2012. Mitophagy: A Complex Mechanism of Mitochondrial Removal.

Antioxid. Redox Signal. doi:10.1089/ars.2011.4407
Ott, M., Robertson, J.D., Gogvadze, V., Zhivotovsky, B., Orrenius, S., 2002.
Cytochrome c release from mitochondria proceeds by a two-step process. Proc.
Natl. Acad. Sci. U. S. A. 99, 125963. doi:10.1073/pnas.241655498
Palella, F.J., Delaney, K.M., Moorman, A.C., Loveless, M.O., Fuhrer, J., Satten, G.A.,
Aschman, D.J., Holmberg, S.D., 1998. Declining Morbidity and Mortality among
Patients with Advanced Human Immunodeficiency Virus Infection. N. Engl. J. Med.
338, 853860. doi:10.1056/NEJM199803263381301
Pedrol, E., Milinkovic, A., Soler, A., Nunes, V., Casademont, J., Gatell, J.M.,
Cardellach, F., n.d. Mitochondrial effects of antiretroviral therapies in
asymptomatic patients. Antivir. Ther. 4755.
Pilon, A.A., Lum, J.J., Phenix, B.N., Douglas, R., Badley, A.D., 2002. Induction of
Apoptosis by a Nonnucleoside Human Immunodeficiency Virus Type 1 Reverse
Transcriptase Inhibitor. Antimicrob. Agents Chemother. 46, 26872691.
doi:10.1128/AAC.46.8.2687
Pinti, M., Nasi, M., Gibellini, L., Roat, E., Biasi, S. De, Bertoncelli, L., Cossarizza, A.,
2010. The Role of Mitochondria in HIV Infection and Its Treatment. J. Exp. Clin.
Med. 2, 145155. doi:10.1016/S1878-3317(10)60024-1
Ramachandran, G., Kumar, A.K.H., Rajasekaran, S., Kumar, P., Ramesh, K., Anitha,
S., Narendran, G., Menon, P., Gomathi, C., Swaminathan, S., 2009. CYP2B6 G516T
Polymorphism but Not Rifampin Coadministration Influences Steady-State
Pharmacokinetics of Efavirenz in Human Immunodeficiency Virus-Infected
Patients in South India . Antimicrob. Agents Chemother. 53, 863868.
doi:10.1128/AAC.00899-08
Repnik, U., Turk, B., 2010. Lysosomal-mitochondrial cross-talk during cell death.
Mitochondrion 10, 6629. doi:10.1016/j.mito.2010.07.008
Riedl, S.J., Li, W., Chao, Y., Schwarzenbacher, R., Shi, Y., 2005. Structure of the
apoptotic protease-activating factor 1 bound to ADP. Nature 434, 926933.
doi:10.1038/nature03465
Ross, M.F., Da Ros, T., Blaikie, F.H., Prime, T.A., Porteous, C.M., Severina, I.I.,
Skulachev, V.P., Kjaergaard, H.G., Smith, R.A.J., Murphy, M.P., 2006. Accumulation
of lipophilic dications by mitochondria and cells. Biochem. J. 400, 199208.
doi:10.1042/BJ20060919
Scorrano, L., 2009. Opening the doors to cytochrome c: changes in mitochondrial
shape and apoptosis. Int. J. Biochem. Cell Biol. 41, 187583.
doi:10.1016/j.biocel.2009.04.016
SM, H., JJ, E., P, R., et al, 2008. Antiretroviral treatment of adult hiv infection:
2008 recommendations of the international aids societyusa panel. JAMA 300,
555570. doi:10.1001/jama.300.5.555

Soldani, C., Scovassi, A.I., 2002. Poly(ADP-ribose) polymerase-1 cleavage during

apoptosis: An update. Apoptosis. doi:10.1023/A:1016119328968
Stankov, M. V, Lcke, T., Das, A.M., Schmidt, E., Behrens, G.M.N., Lu, T., 2010.
Mitochondrial DNA Depletion and Respiratory Chain Activity in Primary Human
Subcutaneous Adipocytes Treated with Nucleoside Analogue Reverse
Transcriptase Inhibitors Mitochondrial DNA Depletion and Respiratory Chain
Activity in Primary Human Subcutaneous. Antimicrob. Agents Chemother.
doi:10.1128/AAC.00914-09
Tashima, K.T., Bausserman, L., Alt, E.N., Aznar, E., Flanigan, T.P., 2003. Lipid
changes in patients initiating efavirenz- and indinavir-based antiretroviral
regimens., HIV Clinical Trials.
Telenti, A., Zanger, U.M., 2008. Pharmacogenetics of anti-HIV drugs. Annu. Rev.
Pharmacol. Toxicol. 48, 227256.
Twiddy, D., Cain, K., 2007. Caspase-9 cleavage, do you need it? Biochem. J. 405,
e12. doi:10.1042/BJ20070617
Usach, I., Melis, V., Peris, J.-E., 2013. Non-nucleoside reverse transcriptase
inhibitors: a review on pharmacokinetics, pharmacodynamics, safety and
tolerability. J. Int. AIDS Soc. 16, 114. doi:10.7448/ias.16.1.18567
Walker, U.A., Jochen, B., Gatell, M., Mallolas, J., The, D., n.d. Depletion of
Mitochondrial DNA in Liver Under Antiretroviral Therapy With Didanosine,
Stavudine, or Zalcitabine . Hepatology 311317. doi:10.1002/hep.20074
Wasilewski, M., Scorrano, L., 2009. The changing shape of mitochondrial
apoptosis. Trends Endocrinol. Metab. 20, 28794. doi:10.1016/j.tem.2009.03.007
Youle, R.J., Narendra, D.P., 2011. Mechanisms of mitophagy. Nat. Rev. Mol. Cell
Biol. 12, 914. doi:10.1038/nrm3028
Zhu, Y., Li, M., Wang, X., Jin, H., Liu, S., Xu, J., Chen, Q., 2012. Caspase cleavage
of cytochrome c1 disrupts mitochondrial function and enhances cytochrome c
release. Cell Res. 22, 12741. doi:10.1038/cr.2011.82